Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.30 $3.38 Friday, 10th May 2024 CLLS stock ended at $3.06. This is 5.56% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.00% from a day low at $3.00 to a day high of $3.27.
90 days $2.30 $3.38
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Jun 01, 2016 $32.43 $32.88 $32.17 $32.51 73 958
May 31, 2016 $32.14 $32.94 $31.99 $32.78 120 149
May 27, 2016 $31.37 $31.57 $31.05 $31.22 117 723
May 26, 2016 $31.55 $31.80 $31.00 $31.71 85 339
May 25, 2016 $30.87 $31.63 $30.72 $31.45 86 976
May 24, 2016 $31.02 $31.44 $30.74 $31.26 111 867
May 23, 2016 $30.60 $31.66 $30.60 $31.27 193 992
May 20, 2016 $29.11 $30.90 $29.11 $30.78 198 117
May 19, 2016 $29.06 $29.78 $28.92 $29.25 167 057
May 18, 2016 $29.77 $29.99 $29.29 $29.33 164 137
May 17, 2016 $30.76 $31.21 $29.71 $29.88 98 114
May 16, 2016 $30.10 $31.49 $30.10 $31.39 189 500
May 13, 2016 $29.65 $31.41 $29.65 $30.00 243 909
May 12, 2016 $31.13 $31.19 $29.07 $29.65 297 636
May 11, 2016 $31.48 $32.25 $30.90 $30.94 210 082
May 10, 2016 $32.69 $32.84 $31.52 $32.10 154 334
May 09, 2016 $32.80 $34.99 $32.06 $33.38 557 839
May 06, 2016 $27.00 $31.22 $27.00 $30.92 285 082
May 05, 2016 $27.00 $27.73 $26.90 $26.95 99 584
May 04, 2016 $26.90 $27.36 $26.85 $27.26 151 467
May 03, 2016 $27.56 $27.71 $26.79 $27.03 90 679
May 02, 2016 $26.97 $27.76 $26.97 $27.66 81 492
Apr 29, 2016 $27.65 $28.07 $27.21 $27.21 67 256
Apr 28, 2016 $27.87 $28.37 $27.63 $27.65 59 940
Apr 27, 2016 $27.86 $27.95 $27.46 $27.55 60 324
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT